We are live on ! Find out more
NAH

Neumann Advisory (HK) Portfolio holdings

AUM $356M
1-Year Est. Return 37.48%
This Fund
S&P 500
This Quarter Est. Return
+4.95%
1 Year Est. Return
+37.48%
3 Year Est. Return
+88.43%
5 Year Est. Return
+77.84%
10 Year Est. Return
AUM
$568M
AUM Growth
+$39.1M
Cap. Flow
+$40.8M
Cap. Flow %
7.19%
Top 10 Hldgs %
99.64%
Holding
11
New
1
Increased
4
Reduced
3
Closed

Top Buys

Rank Stock Value
1
XPEV icon
XPeng
XPEV
+$32.8M
2
API
Agora
API
+$6.73M
3
MRNA icon
Moderna
MRNA
+$4.94M
4
TSLA icon
Tesla
TSLA
+$340K

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$11.5M
2
META icon
Meta Platforms (Facebook)
META
+$2.75M
3
ZTO icon
ZTO Express
ZTO
+$2.24M

Sector Composition

Rank Sector Weight
1 Technology 43.14%
2 Consumer Discretionary 36.65%
3 Communication Services 5.52%
4 Industrials 1.6%
5 Healthcare 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
1
Tesla
TSLA
$1.22T
$144M 25.35%
646,353
+1,353
+0.2% +$340K
TWLO icon
2
Twilio
TWLO
$27.7B
$129M 22.78%
379,574
API
3
Agora
API
$327M
$116M 20.36%
2,299,587
+106,653
+5% +$6.73M
XPEV icon
4
XPeng
XPEV
$12.1B
$36.3M 6.39%
993,758
+788,758
+385% +$32.8M
META icon
5
Meta Platforms (Facebook)
META
$1.54T
$31.3M 5.52%
106,372
-10,200
-9% -$2.75M
BABA icon
6
Alibaba
BABA
$276B
$27.9M 4.92%
123,133
-46,867
-28% -$11.5M
ZTO icon
7
ZTO Express
ZTO
$18.4B
$9.08M 1.6%
311,496
-68,504
-18% -$2.24M
TIGR
8
UP Fintech Holding
TIGR
$872M
$4.94M 0.87%
277,567
MRNA icon
9
Moderna
MRNA
$22.9B
$4.46M 0.79%
+34,067
New +$4.94M
SVA
10
DELISTED
Sinovac Biotech, Ltd
SVA
$2.04M 0.36%
315,586

Similar funds

Neumann Advisory (HK)'s Q1 2021 Portfolio in Review

As of Q1 2021, Neumann Advisory (HK) held 11 positions worth $568M, up 7.4% from $529M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Neumann Advisory (HK) deployed $40.8M of net new capital in Q1 2021, opening 1 new position and adding to 4 existing holdings. Its largest new stake was Moderna: 34,067 shares worth $4.46M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 41% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Alibaba, an estimated $11.5M trimmed.

  • Neumann Advisory (HK)'s largest Q1 2021 buy was Moderna: 34,067 shares worth $4.46M.
  • Neumann Advisory (HK) added most to XPeng in Q1 2021, an estimated $32.8M increase.
  • Neumann Advisory (HK)'s biggest Q1 2021 reduction was Alibaba, cutting an estimated $11.5M.
  • Neumann Advisory (HK)'s ten largest holdings make up 100% of its $568M portfolio in Q1 2021.
  • Neumann Advisory (HK) opened 1 new position and closed 0 in Q1 2021.
  • Neumann Advisory (HK)'s portfolio value rose 7.4% quarter-over-quarter to $568M.

Based on Neumann Advisory (HK)'s 13F filing for Q1 2021, filed 8 Apr 2021.